Article
Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?
11 Apr 2023
Abstract excerpt
The ability to identify the broadest range of targetable gene fusions is crucial to facilitate personalized therapy selection for advanced lung adenocarcinoma (LuADs) patients harboring targetable receptor tyrosine kinase (RTK) genomic alterations. In order to evaluate the most effective testing approach for LuAD targetable gene fusion detection, we analyzed 210 NSCLC selected clinical samples, comparing in situ...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
